|1.||Wang, Jian: 1 article (06/2015)|
|2.||Lu, Wenju: 1 article (06/2015)|
|3.||Jia, Jing: 1 article (06/2015)|
|4.||Zhao, Mingming: 1 article (06/2015)|
|5.||Wang, Sabrina: 1 article (06/2015)|
|6.||Xu, Lei: 1 article (06/2015)|
|7.||Jiang, Haiyang: 1 article (06/2015)|
|8.||Zhang, Jie: 1 article (06/2015)|
|9.||Yang, Kai: 1 article (06/2015)|
|10.||Kallioniemi, Anne: 1 article (01/2013)|
01/01/2013 - "We performed a concurrent survey of gremlin 1 and noggin protein expression in multiple normal and cancer samples, using immunohistochemistry on tissue microarrays containing 96 samples from 34 different normal organs/tissue sites and 208 samples of 34 different tumor types. "
08/01/2012 - "We explored the effect of Noggin protein expression on tumor growth in vivo by using fluorescence imaging. "
08/01/2012 - "Orthotopic expression of noggin protein in cancer cells inhibits human lung carcinoma growth in vivo."
07/01/2008 - "Mutations in the NOG gene which encodes the noggin protein, a bone morphogenetic protein antagonist, have been identified in TCS as well as in four other autosomal dominant disorders including proximal symphalangism (SYM1), multiple synostosis (SYNS1), Tarsal-Carpal coalition syndrome and brachydactyly type B (BDB). "
06/01/2015 - "Then, by using treatment of extrogenous recombinant noggin protein, we further found that noggin significantly normalized 1) BMP4-induced phosphorylation of cellular p38 and ERK1/2; 2) BMP4-induced phosphorylation of cellular JAK2 and STAT3; 3) hypoxia-induced PASMC proliferation; 4) hypoxia-induced store-operated calcium entry (SOCE), and 5) hypoxia-increased expression of transient receptor potential cation channels (TRPC1 and TRPC6) in PASMC. "
|1.||Bone Morphogenetic Proteins (Bone Morphogenetic Protein)
|3.||Tarsal carpal coalition syndrome